About the Authors
- Rufayda Mruwat
-
Affiliation Department of Biochemistry, Hebrew University Medical School, Jerusalem, Israel
- Saul Yedgar
-
* E-mail: yedgar@md.huji.ac.il
Affiliation Department of Biochemistry, Hebrew University Medical School, Jerusalem, Israel
- Iris Lavon
-
Affiliation Department of Neurology, Hadassah University Hospital, Jerusalem, Israel
- Amiram Ariel
-
Affiliation Department of Biology, Faculty of Natural Sciences, University of Haifa, Haifa, Israel
- Miron Krimsky
-
Affiliations Department of Neurology, Hadassah University Hospital, Jerusalem, Israel, Pediatric Department, Hadassah University Hospital, Jerusalem, Israel
- David Shoseyov
-
Affiliation Pediatric Department, Hadassah University Hospital, Jerusalem, Israel
Competing Interests
The study used a compound (PLA2 inhibitor) proprietary of Celsus Therapeutics Plc. S. Yedgar serves on the board of the company and has shares in it. All other authors have no competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RM SY IL AA MK DS. Performed the experiments: RM MK DS. Analyzed the data: RM SY IL AA DS. Contributed reagents/materials/analysis tools: IL AA MK DS. Wrote the paper: RM SY DS.